California State Teachers Retirement System (CalSTRS)’s GT Biopharma GTBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-251
Closed -$22K 3208
2022
Q1
$22K Sell
251
-73
-23% -$6.44K ﹤0.01% 3159
2021
Q4
$30K Buy
324
+4
+1% +$599 ﹤0.01% 3214
2021
Q3
$65K Sell
320
-776
-71% -$234K ﹤0.01% 3080
2021
Q2
$510K Buy
+1,096
New +$455K ﹤0.01% 2624

Other funds holding GTBP

California State Teachers Retirement System (CalSTRS)'s GTBP Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of GT Biopharma (GTBP) in Q2 2022, closing a stake of 251 shares — an estimated $22K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in GTBP in Q2 2021 and held it in 4 quarters. The position peaked at $510K in Q2 2021. 47 funds tracked by Wall St. Rank hold GTBP as of Q2 2022.

  • California State Teachers Retirement System (CalSTRS) reported no remaining GT Biopharma position as of Q2 2022 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 251 GT Biopharma shares in Q2 2022, an estimated $22K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in GT Biopharma in Q2 2021 and held it in 4 quarters.
  • California State Teachers Retirement System (CalSTRS)'s GT Biopharma position peaked at $510K in Q2 2021.
  • 47 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.